Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiner, H. L.
Right arrow Articles by Schocket, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiner, H. L.
Right arrow Articles by Schocket, A. L.
NEUROLOGY 1979;29:1504
© 1979 American Academy of Neurology

Lymphocytes in multiple sclerosis

Correlation with CSF immunoglobulins and cold-reactive lymphocytotoxic antibodies

Howard L. Weiner, M.D. and Alan L. Schocket, M.D.

Department of Neurology and Division of Clinical Immunology, Department of Medicine, University of Colorado Medical Center, Denver, Colorado.

Lymphocyte profiles were studied in patients with multiple sclerosis (MS) and normal controls. Apart from cold-reactive lymphocytotoxic antibodies (LCA), which were elevated in MS patients, there was no difference between MS patients and normal controls in terms of lymphocyte subpopulations, serum immunoglobulins, or responses to mitogens. There was no correlation between LCA and any of the immunologic characteristics measured. However, there was a correlation between immunoglobulin-bearing cells in the peripheral blood of MS patients and cerebrospinal fluid (CSF) levels of immunoglobulin and CSF viral antibodies. These results suggest that cold-reactive lymphocytotoxic antibodies do not affect lymphocyte function in patients with MS. that antigens stimulating "local" central nervous system (CNS) antibody production may be located outside the CNS and that locally produced CNS antibody may be made by immunoglobulin-bearing cells that migrate to the CSF from the periphery after exposure to antigen.


Address reprint requests to Dr. Weiner, Neurology Section, Peter Bent Brigham Hospital, Harvard Medical School, 721 Huntington Avenue, Boston, MA 02115.

Supported in part by National Multiple Sclerosis Society Grant No. KG-812-B-2, National Institute of Health Grant No. NS-10590, and a Fellowship from the Colorado Multiple Sclerosis Society.

Accepted for publication April 6, 1979.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by AAN Enterprises, Inc.